iBio (NYSEMKT:IBIO) Trading 0.4% Higher – Here’s What Happened

iBio, Inc. (NYSEMKT:IBIO) rose 0.4% on Friday . The stock traded as high as $2.99 and last traded at $2.86. Approximately 103,267 shares traded hands during trading, a decline of 9% from the average daily volume of 113,212 shares. The stock had previously closed at $2.85.

iBio Stock Performance

The company has a 50 day moving average of $2.10 and a two-hundred day moving average of $2.10. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.04.

About iBio

iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.